Tanja Eichhorn

Tanja Eichhorn, PhD, is affiliated with the Center for Biomedical Technology at the University for Continuing Education Krems. Her research focuses on extracellular vesicles, immunothrombosis, sepsis, and blood product analysis. She explores how these vesicles influence disease mechanisms, particularly in conditions like SARS-CoV-2 infection and sepsis.

Her work integrates biomedical engineering, hematology, and immunology to advance diagnostics and therapies. Recent studies address extracellular vesicle stability in blood products, cytokine profiles in critically ill patients, and biomaterials for therapeutic apheresis. She collaborates on projects like heparin-functionalized adsorbents to mitigate immunothrombosis.

Publications highlight her contributions to understanding platelet- immune cell interactions, histone roles in sepsis outcomes, and lateral flow assay performance for SARS-CoV-2 detection. Her research bridges basic science and clinical applications, with implications for blood banking, critical care, and infectious disease management.